This study evaluates the clinical efficacy of #regorafenib in combination with #avelumab in mTLS-negative #SoftTissueSarcoma patients, highlighting the potential of #antiangiogenic agents to modify the #TumorMicroEnvironment. #medsky
#STTT #OpenAccess: doi.org/10.1038/s413...